Ripertamab (SCT400) 是一种重组人鼠嵌合抗CD20IgG1κ 单抗。Ripertamab 可用于血液系统恶性肿瘤，包括非霍奇金淋巴瘤 (NHL) 的研究。
| 生物活性 | Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL)[1]. |
| CAS 号 | |
| 中文名称 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
